-5%
Catium Trio is a powder-based inhalation drug formulated for oral inhalation via a specialized inhalation device. It delivers a powerful combination of three active ingredients for effective asthma management:
✔ Indacaterol Acetate (Ultra-LABA – Long-Acting Beta-2 Agonist)
✔ Glycopyrronium Bromide (Ultra-LAMA – Long-Acting Muscarinic Antagonist)
✔ Mometasone Furoate (ICS – Inhaled Corticosteroid)
Each component plays a crucial role in bronchodilation, airway relaxation, and inflammation reduction, providing enhanced lung function and long-term asthma symptom control.
Catium Trio is a prescription inhalation medication indicated for the long-term maintenance treatment of asthma in adult patients who are not adequately controlled with a combination of a long-acting β2-agonist (LABA) and an inhaled corticosteroid (ICS). It also helps to reduce the frequency and severity of asthma exacerbations, ensuring better respiratory control.